AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Summary
•
Strive Inc. (NASDAQ: ASST) is in freefall, trading at 69% of its 52-week high amid a perfect storm of financial underperformance and strategic uncertainty. With a 31.5% intraday drop and a -996.1% EBIT margin, the stock’s collapse reflects deepening doubts over management’s ability to stabilize operations. The options market is now pricing in extreme volatility, with 143.87% implied volatility on the October 24 $1 call option. This is a high-risk, high-reward scenario for traders navigating a stock on the brink of a potential turnaround or further collapse.
Leadership Vacuum and Operational Bleeding Trigger Sell-Off
ASST’s 31.5% plunge stems from a confluence of red flags: a -996.1% EBIT margin, $2.66M net loss, and a 1300.47 price-to-sales ratio that signals investor skepticism. Recent news of Vivek Ramaswamy’s Strive merging with
Options Playbook: Capitalizing on ASST’s Volatility
• RSI: 11.03 (oversold)
• MACD: -0.853 (bearish), Signal Line: -0.7376
• Bollinger Bands: $0.793–$5.277 (extreme range)
• 200D MA: $3.06 (well below current price)
ASST’s technicals scream of a short-term bottoming process. The RSI at 11.03 suggests overselling, while the MACD histogram (-0.1157) indicates bearish momentum. However, the stock is trading near its lower Bollinger Band ($0.793), hinting at potential mean reversion. For options traders, the October 24 $1 call (ASST20251024C1) and October 31 $1 call (ASST20251031C1) stand out:
• ASST20251024C1
- IV: 143.87% (extreme volatility)
- Delta: 0.660 (moderate sensitivity)
- Theta: -0.00617 (rapid time decay)
- Gamma: 1.306 (high sensitivity to price swings)
- Turnover: 8,081 (liquid)
- Leverage: 7.17%
- Payoff (5% downside): $0.05 (max(0, 1.0125 - 1))
- Why it works: High gamma and IV make this a speculative bet on a short-term rebound. The 7.17% leverage amplifies gains if the stock rallies.
• ASST20251031C1
- IV: 169.10% (extreme)
- Delta: 0.650 (moderate)
- Theta: -0.005105 (rapid decay)
- Gamma: 0.8929 (high sensitivity)
- Turnover: 19,032 (liquid)
- Leverage: 5.37%
- Payoff (5% downside): $0.05 (max(0, 1.0125 - 1))
- Why it works: The 169.10% IV and 5.37% leverage create a high-risk, high-reward scenario. Ideal for aggressive bulls expecting a post-merger bounce.
Action: Aggressive bulls may consider ASST20251031C1 into a bounce above $1.05. If $0.94 breaks, the October 31 $1 put (ASST20251031P1) offers downside protection.
Backtest Strive Stock Performance
Here is the completed one-click back-test of the “RSI Oversold 1-Day Hold” strategy on NVDA (2022-01-01 → 2025-10-13). Key take-aways • Entry rule: Buy at next day’s close whenever the 14-day RSI < 30 (classic “oversold” threshold). • Exit rule: Close the position after exactly one trading day. • Automatic settings: – RSI period fixed at the standard 14 days. – Max-holding-days = 1 used instead of a separate close signal. • Performance snapshot: total strategy return ≈ 29.7 %, annualised ≈ 8.0 %, max drawdown ≈ 12.9 %, Sharpe ≈ 0.53. Interactively explore the full equity curve and trade list in the module below.Feel free to drill down into individual trades and risk statistics via the interactive panel.
ASST at Crossroads: Bet on Turnaround or Exit the Wreck
ASST’s 31.5% drop has created a binary scenario: either a strategic overhaul by management triggers a rebound, or the stock continues its descent toward the $0.335 52-week low. The options market is pricing in extreme volatility, with 143.87% IV on the October 24 $1 call. Traders should monitor the $1.05 support level and the October 31 merger vote. Meanwhile, sector leader BlackRock (BLK) is up 2.45%, highlighting the contrast between ASST’s turmoil and broader asset management strength. Watch for $0.94 breakdown or a post-merger catalyst—this is a high-risk, high-reward trade with no middle ground.

TickerSnipe provides professional intraday stock analysis using technical tools to help you understand market trends and seize short-term trading opportunities.

Nov.13 2025

Nov.13 2025

Nov.13 2025

Nov.13 2025

Nov.13 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet